Trial Profile
A Multicenter, Double-Blind, Randomized, Placebo Controlled Study to Estimate the Effect of Anakinra (r-metHuIL-1ra) on Vaccine Antibody Response in Subjects With Rheumatoid Arthritis (RA)
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 08 Nov 2021
Price :
$35
*
At a glance
- Drugs Anakinra (Primary) ; Diphtheria-tetanus vaccine
- Indications Diphtheria; Rheumatoid arthritis; Tetanus
- Focus Pharmacodynamics
- Sponsors Amgen
- 05 Nov 2010 New trial record.